Overall, the immunohistochemical data indicate that a significant proportion of bladder carcinomas, invasive breast carcinomas, colon adenocarcinomas, lung squamous cell carcinomas, PDACs and prostate adenocarcinomas display expression of CDCP1 protein that is markedly elevated above levels seen in normal tissues. The gene discussed is CDCP1; the disease is squamous cell lung carcinoma.